VetClick
Menu Menu
Login

VetClick

/ News
Saturday, 4th May 2024 | 4,382 veterinary jobs online | 124 people actively seeking work | 5,486 practices registered

Veterinary Industry News

Send us your news

Nearly Half Of Participating Vets Say They'll Change Treatment Protocols For Adrenal Disease And Reproduction Management After Watching Ferret Medicine Webinar

12 years ago
3853 views

Posted
26th October, 2012 13h08


Ferret Almost half of participating vets said they would change their treatment protocols for adrenal disease and reproduction management as a result of recent webinar on Ferret Medicine. Led by John Chitty BVetMed CertZooMed CBiol MSB MRCVS, the webinar, which took place on 12 September, was viewed by more than 600 practices, making it the most popular CPD event hosted by The Webinar Vet this year. Commenting, John Chitty said: “I provided an overview of treatment protocols for all of the common diseases but focused on adrenal disease as it’s highly prevalent in neutered ferrets but may be reduced by the routine use of deslorelin implants. These implants can also be used to avoid surgical neutering.” According to a post-webinar questionnaire, 33% of clinicians said that they saw ferrets more than five times a year. “This confirms what we thought: ferrets are being presented more and more in practice and so education on this species is vital,” said Chris Geddes MRCVS, Product Manager at Virbac. “An amazing 41% of respondents said that they would change their protocols for reproduction management and 40% their treatment of adrenal disease following the webinar, showing how useful it was to those attending.” For those who were unable to see it at the time, the webinar can now be viewed by visiting www.virbac.co.uk.  A CPD certificate is also available for download as are six other webinars previously sponsored by Virbac. The company recently announced that it has gained a marketing authorisation for the use of Suprelorin 9.4mg in male ferrets.  Suprelorin, a slow-release implant containing the gonadotropin-releasing hormone (GnRH) agonist deslorelin, offers temporary sterilisation without the need for surgery. Founded by a veterinary surgeon, Virbac is the largest independent veterinary pharmaceutical company in the world and is dedicated to supporting the veterinary profession through the development of innovative products and services, which support their businesses and help animals lead longer, healthier lives.

More from


You might be interested in...